Skip to content

Clinical trials

Expanded access trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Available5
No longer available4
Approved for marketing3
Temporarily not available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Beijing Anzhen Hospital1
Fuda Cancer Hospital, Guangzhou1
Institute of Hematology & Blood Diseases Hospital, China1
Louqiang Zhang1
Ming Zhao1
Novartis1
Peking University1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shandong Cancer Hospital and Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Abnormalities, Multiple1
Breast Neoplasms1
Carcinoma, Hepatocellular1
Colorectal Neoplasms1
Fanconi Anemia1
Gastrointestinal Stromal Tumors1
Hematologic Neoplasms1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Mandibular Fractures1
Multiple Myeloma1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.